Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Biofilms provide refuge for cancerous bacteria: Familial adenomatous polyposis (FAP) causes benign polyps along the colon. If left untreated, FAP leads to a high incidence of colon cancer. To understand how polyps influence tumor formation, Dejea et al. examined the colonic mucosa of FAP patients. They discovered biofilms containing the carcinogenic versions of the bacterial species Escherichia coli and Bacteroides fragilis . Colon tissue from FAP patients exhibited greater expression of two bacterial genes that produce secreted oncotoxins. Studies in mice showed that specific bacteria could work together to induce colon inflammation and tumor formation. Science , this issue p. 592
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“intratumor microbes have been reported to have cancer-specific effects on (i) gastrointestinal and urinary tract mutagenesis via secreted genotoxins, most notably pks+ E. coli-derived colibactin and B. fragilis-derived toxin (22, 37, 38, 40, 41)”
From The microbiome and human cancer (2021) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They affect gastrointestinal and urinary tract mutagenesis by secreting genotoxins [411, 412, 413]”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [412]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These pks-positive E. coli strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [154]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Increasing evidence suggests an important additional category of “complicit” microbes and microbial functions that promote carcinogenesis but are insufficient to cause cancer (18, 20, 25, 38, 44–47).”
From The microbiome and human cancer (2021) · cites this paper as [38]
In the citing paper
“Higher proportions of patients with familial adenomatous polyposis42 or sporadic premalignant lesions had intestinal mucosa that tested positive for ETBF than of controls.41”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Self-citationMicrobiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
Self-citationThe Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
Self-citationComparative study of the intestinal mucus barrier in normal and inflamed colon
Swidsinski, A., Loening-Baucke, V., Theissig, F., Engelhardt, H., Bengmark, S., Koch, S., Lochs, H., & Dorffel, Y. (2007) · Gut · doi:10.1136/gut.2006.098160 · Cited by 365
Metabolism Links Bacterial Biofilms and Colon Carcinogenesis
Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., Ivanisevic, J., Cho, K., Wick, E. C., Hechenbleikner, E. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.011 · Cited by 351
Self-citationRhee, K.-J., Wu, S., Wu, X., Huso, D. L., Karim, B., Franco, A. A., Rabizadeh, S., Golub, J. E., Mathews, L. E., Shin, J., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00814-08 · Cited by 297
Self-citationProrok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236
Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease
Prindiville, T. P., Sheikh, R. A., Cohen, S. H., Tang, Y. J., Cantrell, M. C., & Silva, J. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0602.000210 · Cited by 199
Research works printed but not linked: 1
- Swidsinski A Loening-Baucke V Herber A J Physiol Pharmacol 60 suppl 6 61 71 2009 20224153
Cited by
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
“, 2017), ability to form biofilms and initiate the outgrowth of the consortia of invasive bacteria (Dejea et al., 2018; Tomkovich et al., 2019) or ability to induce low grade inflammation disrupting the barrier (Wu et al.”
BackgroundThe IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Mucus-invasive bacterial biofilms of B fragilis, F nucleatum, Peptostreptococcus stomatis, Gemella morbilliform, and Parvimonas micra associate with tumors in patients with familial adenomatous polyposis(Dejea et al., 2018; Dejea et al., 2014).”
BackgroundWirbel, J., Pyl, P. T., Kartal, E., Zych, K., Kashani, A., Milanese, A., Fleck, J. S., Voigt, A. Y., Palleja, A., Ponnudurai, R., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0406-6 · Cited by 1,373
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Mager, L. F., Burkhard, R., Pett, N., Cooke, N. C. A., Brown, K., Ramay, H., Paik, S., Stagg, J., Groves, R. A., Gallo, M., et al. (2020) · Science · doi:10.1126/science.abc3421 · Cited by 1,407
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
“fragilis–derived toxin (22, 37, 38, 40, 41); (ii) CagA-mediated or IL-17– producing gd T cell–mediated inflammation in stomach and lung cancers, respectively (18, 103); (iii) chemoresistance through direct microbial metabolism (cytidine deaminase degradation of gemcitabine) in pancreatic cancer or indirect amplificati…”
BackgroundGut Bacteroides species in health and disease
Zafar, H., & Saier, M. H. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1848158 · Cited by 1,233
“In addition, Bfr may enhance the colonization of certain enteric pathogens in individuals with hereditary conditions leading to the formation of certain cancer types.(135) Another mechanism that may lead to cancer formation in the colon involves biofilms produced by certain Bacteroides spp.”
BackgroundMutational signature in colorectal cancer caused by genotoxic pks+ E. coli
Pleguezuelos-Manzano, C., Puschhof, J., Rosendahl Huber, A., van Hoeck, A., Wood, H. M., Nomburg, J., Gurjao, C., Manders, F., Dalmasso, G., Stege, P. B., et al. (2020) · Nature · doi:10.1038/s41586-020-2080-8 · Cited by 1,208
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
Brennan, C. A., & Garrett, W. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0129-6 · Cited by 1,205
Bacterial Biofilm and its Role in the Pathogenesis of Disease
Vestby, L. K., Grønseth, T., Simm, R., & Nesse, L. L. (2020) · Antibiotics · doi:10.3390/antibiotics9020059 · Cited by 1,105
“fragilis has been proposed as an initiator of colorectal cancer due to its ability to disturb the epithelial homeostasis and influence cell proliferation [96,97].”
BackgroundInfluentialThomas, A. M., Manghi, P., Asnicar, F., Pasolli, E., Armanini, F., Zolfo, M., Beghini, F., Manara, S., Karcher, N., Pozzi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0405-7 · Cited by 1,030
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Poore, G. D., Kopylova, E., Zhu, Q., Carpenter, C., Fraraccio, S., Wandro, S., Kosciolek, T., Janssen, S., Metcalf, J., Song, S. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2095-1 · Cited by 989
RetractedA Review of Cancer Immunotherapy: From the Past, to the Present, to the Future
Esfahani, K., Roudaia, L., Buhlaiga, N., Del Rincon, S. V., Papneja, N., & Miller, W. H. (2020) · Current Oncology · doi:10.3747/co.27.5223 · Cited by 954
The Intestinal Microbiota in Colorectal Cancer.
Tilg, H., Adolph, T. E., Gerner, R. R., & Moschen, A. R. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.004 · Cited by 777
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752
The inflammatory pathogenesis of colorectal cancer
Schmitt, M., & Greten, F. R. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00534-x · Cited by 775
Short-chain fatty acids in diseases
Zhang, D., Jian, Y.-P., Zhang, Y.-N., Li, Y., Gu, L.-T., Sun, H.-H., Liu, M.-D., Zhou, H.-L., Wang, Y.-S., & Xu, Z.-X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01219-9 · Cited by 718
“The abundance of Escherichia coli and Bacteroides fragilis is reportedly higher in the intestines of patients with CRC, whereas the abundance of typical SCFA-producing bacteria, such as A. muciniphila, are significantly reduced (Table 2) [106, 107].”
BackgroundGut microbiota in colorectal cancer development and therapy
Wong, C. C., & Yu, J. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00766-x · Cited by 721
Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier
Martens, E. C., Neumann, M., & Desai, M. S. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0036-x · Cited by 711
The Human Gut Bacterial Genotoxin Colibactin Alkylates DNA
Wilson, M. R., Jiang, Y., Villalta, P. W., Stornetta, A., Boudreau, P. D., Carrá, A., Brennan, C. A., Chun, E., Ngo, L., Samson, L. D., et al. (2019) · Science · doi:10.1126/science.aar7785 · Cited by 635
Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis
Gogokhia, L., Buhrke, K., Bell, R., Hoffman, B., Brown, D. G., Hanke-Gogokhia, C., Ajami, N. J., Wong, M. C., Ghazaryan, A., Valentine, J. F., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.008 · Cited by 609
“, 2012), or in genetically susceptible, non-inflammatory models, such as the APC mouse (Dejea et al., 2018).”
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
Lam, K. C., Araya, R. E., Huang, A., Chen, Q., Di Modica, M., Rodrigues, R. R., Lopès, A., Johnson, S. B., Schwarz, B., Bohrnsen, E., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.019 · Cited by 604
Cullin, N., Azevedo Antunes, C., Straussman, R., Stein-Thoeringer, C. K., & Elinav, E. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.08.006 · Cited by 578
Embracing cancer complexity: Hallmarks of systemic disease
Swanton, C., Bernard, E., Abbosh, C., André, F., Auwerx, J., Balmain, A., Bar-Sagi, D., Bernards, R., Bullman, S., DeGregori, J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.009 · Cited by 540
Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β‐catenin modulator Annexin A1
Rubinstein, M. R., Baik, J. E., Lagana, S. M., Han, R. P., Raab, W. J., Sahoo, D., Dalerba, P., Wang, T. C., & Han, Y. W. (2019) · EMBO reports · doi:10.15252/embr.201847638 · Cited by 525
“These two microorganisms collaboratively enhance early tumorigenesis and mortality in the Apc min/+ mouse model [39].”
Zagato, E., Pozzi, C., Bertocchi, A., Schioppa, T., Saccheri, F., Guglietta, S., Fosso, B., Melocchi, L., Nizzoli, G., Troisi, J., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0649-5 · Cited by 492
“On one side, the increased penetrance or adherence of protumorigenic bacteria which may favor immune cell recruitment and activation, drive tumor cell transformation or Th17 cell activation thus contributing to tumor development 7,29–35 .”
Targeting the gut and tumor microbiota in cancer
Park, E. M., Chelvanambi, M., Bhutiani, N., Kroemer, G., Zitvogel, L., & Wargo, J. A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01779-2 · Cited by 496
(2023) · doi:10.1038/s41392-022-01304-4 · Cited by 460
“coli and Bacteroides fragilis, which together colonize epithelial cells and produce interlukin-17 (IL-17) resulting in massive DNA damage to the epithelium.(73) The toxin (Bft) secreted by B.”
BackgroundA distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche
Zepeda-Rivera, M., Minot, S. S., Bouzek, H., Wu, H., Blanco-Míguez, A., Manghi, P., Jones, D. S., LaCourse, K. D., Wu, Y., McMahon, E. F., et al. (2024) · Nature · doi:10.1038/s41586-024-07182-w · Cited by 451
“Although synergistic interactions between CRC-enriched microbes have previously been reported 61 , it is not clear whether Fna C1 co-occurrence with Fna C2 results in a compounding pathogenic effect.”
BackgroundHost–microbiota maladaptation in colorectal cancer
Janney, A., Powrie, F., & Mann, E. H. (2020) · Nature · doi:10.1038/s41586-020-2729-3 · Cited by 445
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer
Silva-Santos, B., Mensurado, S., & Coffelt, S. B. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0153-5 · Cited by 425
He, Z., Gharaibeh, R. Z., Newsome, R. C., Pope, J. L., Dougherty, M. W., Tomkovich, S., Pons, B., Mirey, G., Vignard, J., Hendrixson, D. R., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317200 · Cited by 409
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 399
Yu, L. C.-H. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0483-8 · Cited by 399
“60% of FAP patients in contrast to 30% in control individuals [113].”
BackgroundLi, R., Zhou, R., Wang, H., Li, W., Pan, M., Yao, X., Zhan, W., Yang, S., Xu, L., Ding, Y., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-019-0312-y · Cited by 386
“to the occurrence [3], development [4], and immunotherapy [5] of colorectal cancer.”
BackgroundSelf-citationTesta, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 374
Understanding and targeting resistance mechanisms in cancer
Lei, Z., Tian, Q., Teng, Q., Wurpel, J. N. D., Zeng, L., Pan, Y., & Chen, Z. (2023) · MedComm · doi:10.1002/mco2.265 · Cited by 347
Screening and prevention of colorectal cancer
Kanth, P., & Inadomi, J. M. (2021) · BMJ · doi:10.1136/bmj.n1855 · Cited by 358
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Zhao, L.-Y., Mei, J.-X., Yu, G., Lei, L., Zhang, W.-H., Liu, K., Chen, X.-L., Kołat, D., Yang, K., & Hu, J.-K. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01406-7 · Cited by 359
“coli, was also shown to induce DNA damage in colonic epithelial cells and correlate with faster cancer onset in patients with familial adenomatous polyposis, a precancerous stage for colon cancer.(12) Mechanistically, colibactin can lead to alkylation and interstrand crosslinks after binding to DNA, which interfere wi…”
BackgroundIntestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD
Kudelka, M. R., Stowell, S. R., Cummings, R. D., & Neish, A. S. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0331-7 · Cited by 355
Polyamines in cancer: integrating organismal metabolism and antitumour immunity
Holbert, C. E., Cullen, M. T., Casero, R. A., & Stewart, T. M. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00473-2 · Cited by 350
The gut microbiota and colon cancer
Garrett, W. S. (2019) · Science · doi:10.1126/science.aaw2367 · Cited by 355
Bacteria in cancer initiation, promotion and progression
El Tekle, G., & Garrett, W. S. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00594-2 · Cited by 343
The gut microbiota and its biogeography
McCallum, G., & Tropini, C. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00969-0 · Cited by 329
“This knowledge will have important implications in treating diseases involving bacterial interactions with host tissue, such as inflammatory bowel disease (IBD) and colorectal cancer (CRC).”
InfluentialOveracre-Delgoffe, A. E., Bumgarner, H. J., Cillo, A. R., Burr, A. H. P., Tometich, J. T., Bhattacharjee, A., Bruno, T. C., Vignali, D. A. A., & Hand, T. W. (2021) · Immunity · doi:10.1016/j.immuni.2021.11.003 · Cited by 318
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
Unexpected guests in the tumor microenvironment: microbiome in cancer
Wong-Rolle, A., Wei, H. K., Zhao, C., & Jin, C. (2021) · Protein & Cell · doi:10.1007/s13238-020-00813-8 · Cited by 313
Microbiota in pancreatic health and disease: the next frontier in microbiome research
Thomas, R. M., & Jobin, C. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0242-7 · Cited by 308
Gut Microbiota in Cancer Immune Response and Immunotherapy
Zhou, C.-B., Zhou, Y.-L., & Fang, J.-Y. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2021.01.010 · Cited by 301
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
Holder, A. M., Dedeilia, A., Sierra-Davidson, K., Cohen, S., Liu, D., Parikh, A., & Boland, G. M. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-024-00705-7 · Cited by 298
Bell, H. N., Rebernick, R. J., Goyert, J., Singhal, R., Kuljanin, M., Kerk, S. A., Huang, W., Das, N. K., Andren, A., Solanki, S., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2021.12.001 · Cited by 296
Chen, F., Dai, X., Zhou, C.-C., Li, K.-X., Zhang, Y.-J., Lou, X.-Y., Zhu, Y.-M., Sun, Y.-L., Peng, B.-X., & Cui, W. (2022) · Gut · doi:10.1136/gutjnl-2020-323476 · Cited by 283
Prebiotics‐Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer
Zheng, D., Li, R., An, J., Xie, T., Han, Z., Xu, R., Fang, Y., & Zhang, X. (2020) · Advanced Materials · doi:10.1002/adma.202004529 · Cited by 274
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Ting, N. L.-N., Lau, H. C.-H., & Yu, J. (2022) · Gut · doi:10.1136/gutjnl-2021-326264 · Cited by 274
“44 49 Simultaneously, chemotherapy can alter microbiota composition, leading to great disparity in interactions between microbes and drugs among different cancers and individuals.”
BackgroundGastrointestinal biofilms in health and disease
Motta, J.-P., Wallace, J. L., Buret, A. G., Deraison, C., & Vergnolle, N. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00397-y · Cited by 270
Revisit gut microbiota and its impact on human health and disease
Ding, R.-X., Goh, W.-R., Wu, R.-N., Yue, X.-Q., Luo, X., Khine, W. W. T., Wu, J.-R., & Lee, Y.-K. (2019) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.12.012 · Cited by 268
“of identifying early postnatal period as an important window for novel intervention methods using probiotics [82].”
BackgroundAbed, J., Maalouf, N., Manson, A. L., Earl, A. M., Parhi, L., Emgård, J. E. M., Klutstein, M., Tayeb, S., Almogy, G., Atlan, K. A., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00400 · Cited by 267
The microbiome in inflammatory bowel diseases: from pathogenesis to therapy
Liu, S., Zhao, W., Lan, P., & Mou, X. (2021) · Protein & Cell · doi:10.1007/s13238-020-00745-3 · Cited by 263
Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma
Zhang, Q., Ma, C., Duan, Y., Heinrich, B., Rosato, U., Diggs, L. P., Ma, L., Roy, S., Fu, Q., Brown, Z. J., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0304 · Cited by 257
“The contribution of MDSCs to colitis-associated tumorigenesis is well established (53, 54), and gut-derived commensal bacteria have emerged as important factors during initiation and promotion of colon cancer (55, 56).”
BackgroundIntratumoural microbiota: a new frontier in cancer development and therapy
Cao, Y., Xia, H., Tan, X., Shi, C., Ma, Y., Meng, D., Zhou, M., Lv, Z., Wang, S., & Jin, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01693-0 · Cited by 253
The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances
Peng, C., Ouyang, Y., Lu, N., & Li, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01387 · Cited by 249
“fragilis in the colon promotes the expression of inflammatory cytokines and accelerates DNA damage (84).”
BackgroundMicrobiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism?
Ternes, D., Karta, J., Tsenkova, M., Wilmes, P., Haan, S., & Letellier, E. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.01.001 · Cited by 251
The role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 248
Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
Cao, Y., Oh, J., Xue, M., Huh, W. J., Wang, J., Gonzalez-Hernandez, J. A., Rice, T. A., Martin, A. L., Song, D., Crawford, J. M., et al. (2022) · Science · doi:10.1126/science.abm3233 · Cited by 247
“fragilis, and Klebsiella oxytoca) (25, 26), we observed that multiple gram-positive microbes from the phylaActinobacteria and Firmicutes also caused substantial DNA damage.”
BackgroundBacteroides and related species: The keystone taxa of the human gut microbiota
Shin, J. H., Tillotson, G., MacKenzie, T. N., Warren, C. A., Wexler, H. M., & Goldstein, E. J. C. (2024) · Anaerobe · doi:10.1016/j.anaerobe.2024.102819 · Cited by 242
The Mechanism of Bacteroides fragilis Toxin Contributes to Colon Cancer Formation
Applied Biomedical Sciences and Biotechnology, S. O. H. S., Cheng, W. T., Kantilal, H. K., Division of Pathology, S. O. M., Davamani, F., & Applied Biomedical Sciences and Biotechnology, S. O. H. S. (2020) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2020.27.4.2 · Cited by 243
Colibactin: More Than a New Bacterial Toxin
Faïs, T., Delmas, J., Barnich, N., Bonnet, R., & Dalmasso, G. (2018) · Toxins · doi:10.3390/toxins10040151 · Cited by 227
“All these studies were performed in Europe (UK [14,15], France [12], and Sweden [13]) and in the USA [76].”
BackgroundOrganoids and organs-on-chips: Insights into human gut-microbe interactions
Puschhof, J., Pleguezuelos-Manzano, C., & Clevers, H. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.04.002 · Cited by 219
Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic
Tomkovich, S., Dejea, C. M., Winglee, K., Drewes, J. L., Chung, L., Housseau, F., Pope, J. L., Gauthier, J., Sun, X., Mühlbauer, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124196 · Cited by 209
Self-citationColorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures
Sobhani, I., Bergsten, E., Couffin, S., Amiot, A., Nebbad, B., Barau, C., de’Angelis, N., Rabot, S., Canoui-Poitrine, F., Mestivier, D., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912129116 · Cited by 218
Bacterial infections and cancer
van Elsland, D., & Neefjes, J. (2018) · EMBO reports · doi:10.15252/embr.201846632 · Cited by 213
“It is also known that bacterial effectors from different species can act synergistically during host cell manipulation and then act in a symbiotic inter-species manner [55,97].”
Microbiota in Tumors: From Understanding to Application
Xie, Y., Xie, F., Zhou, X., Zhang, L., Yang, B., Huang, J., Wang, F., Yan, H., Zeng, L., Zhang, L., et al. (2022) · Advanced Science · doi:10.1002/advs.202200470 · Cited by 209
High fat diet, gut microbiome and gastrointestinal cancer
Tong, Y., Gao, H., Qi, Q., Liu, X., Li, J., Gao, J., Li, P., Wang, Y., Du, L., & Wang, C. (2021) · Theranostics · doi:10.7150/thno.56157 · Cited by 205
“coli, promoting colibactin-induced DNA damage to colonic epithelial cells [143].”
BackgroundBana, B., & Cabreiro, F. (2019) · Annual Review of Genetics · doi:10.1146/annurev-genet-112618-043650 · Cited by 203
Buret, A. G., Motta, J.-P., Allain, T., Ferraz, J., & Wallace, J. L. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-018-0495-4 · Cited by 203
Allen, J., & Sears, C. L. (2019) · Genome Medicine · doi:10.1186/s13073-019-0621-2 · Cited by 204
“coli worked synergistically with ETBF to cause increased DNA damage and increased tumor formation in a mouse model of CRC [59] pks + E.”
BackgroundSelf-citationWu, Q., Qian, W., Sun, X., & Jiang, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01362-9 · Cited by 200
Hanus, M., Parada-Venegas, D., Landskron, G., Wielandt, A. M., Hurtado, C., Alvarez, K., Hermoso, M. A., López-Köstner, F., & De la Fuente, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612826 · Cited by 199
Racial and ethnic disparities in colorectal cancer incidence and mortality
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2021.02.007 · Cited by 190
Lu, H., Xu, X., Fu, D., Gu, Y., Fan, R., Yi, H., He, X., Wang, C., Ouyang, B., Zhao, P., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.07.003 · Cited by 190
Zhao, Y., & Jiang, Q. (2021) · Advances in Nutrition · doi:10.1093/advances/nmaa104 · Cited by 180
“Interestingly, these pathobionts are enriched in colonic mucosal biofilms of familial adenomatous polyposis (57) and in sporadic CRC patients (58).”
BackgroundNew Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
Jain, T., Sharma, P., Are, A. C., Vickers, S. M., & Dudeja, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622064 · Cited by 183
“(45) AOM-treated SPF mice Enterotoxigenic”
The Th17/Treg Cell Balance: A Gut Microbiota-Modulated Story
Cheng, H., Guan, X., Chen, D., & Ma, W. (2019) · Microorganisms · doi:10.3390/microorganisms7120583 · Cited by 178
“Such activities appear to induce increased IL-17 production in the colon and DNA damage within the colonic epithelium that eventually promotes the development of early colon neoplasia [85].”
BackgroundIftekhar, A., Berger, H., Bouznad, N., Heuberger, J., Boccellato, F., Dobrindt, U., Hermeking, H., Sigal, M., & Meyer, T. F. (2021) · Nature Communications · doi:10.1038/s41467-021-21162-y · Cited by 174
Guo, S., Li, L., Xu, B., Li, M., Zeng, Q., Xiao, H., Xue, Y., Wu, Y., Wang, Y., Liu, W., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.289728 · Cited by 173
LaCourse, K. D., Zepeda-Rivera, M., Kempchinsky, A. G., Baryiames, A., Minot, S. S., Johnston, C. D., & Bullman, S. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111625 · Cited by 173
A. Muciniphila Suppresses Colorectal Tumorigenesis by Inducing TLR2/NLRP3-Mediated M1-Like TAMs
Fan, L., Xu, C., Ge, Q., Lin, Y., Wong, C. C., Qi, Y., Ye, B., Lian, Q., Zhuo, W., Si, J., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-1019 · Cited by 168
Natural polysaccharides exhibit anti-tumor activity by targeting gut microbiota
Liu, L., Li, M., Yu, M., Shen, M., Wang, Q., Yu, Y., & Xie, J. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.10.083 · Cited by 169
The microbial landscape of colorectal cancer
White, M. T., & Sears, C. L. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00973-4 · Cited by 161
“It is possible that mucosal biofilm formation serves to promote direct contact of carcinogenic bacteria with the epithelium as demonstrated in a study of patients with familial adenomatous poly-posis showing that ETBF aids invasion of pks + E. coli into the mucus layer 118,133 .”
Self-citationColorectal cancer: the facts in the case of the microbiota
Clay, S. L., Fonseca-Pereira, D., & Garrett, W. S. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155101 · Cited by 166
“fragilis, and the colonic mucosae of these individuals were enriched for genes encoding BFT (bft) and colibactin (clb) (13).”
BackgroundMethodThe microbiome and the hallmarks of cancer
Fulbright, L. E., Ellermann, M., & Arthur, J. C. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006480 · Cited by 164
Saffarian, A., Mulet, C., Regnault, B., Amiot, A., Tran-Van-Nhieu, J., Ravel, J., Sobhani, I., Sansonetti, P. J., & Pédron, T. (2019) · mBio · doi:10.1128/mbio.01315-19 · Cited by 164
Pursuing Human-Relevant Gut Microbiota-Immune Interactions
Spencer, S. P., Fragiadakis, G. K., & Sonnenburg, J. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.002 · Cited by 161
“Crypt resident and mucosal associated microbiota may, despite decreased representation in homogenized stool samples, have a disproportionate impact on the host; including spatial information into studies of intestinal microbiota can reveal important aspects of host-microbe interactions(Campbell et al., 2018; Dejea et…”
BackgroundZhang, J., Haines, C., Watson, A. J. M., Hart, A. R., Platt, M. J., Pardoll, D. M., Cosgrove, S. E., Gebo, K. A., & Sears, C. L. (2019) · Gut · doi:10.1136/gutjnl-2019-318593 · Cited by 157
Self-citationCirculating cell-free DNA for cancer early detection
Gao, Q., Zeng, Q., Wang, Z., Li, C., Xu, Y., Cui, P., Xin, Z., Lu, H., Wang, G., Cai, S., et al. (2022) · The Innovation · doi:10.1016/j.xinn.2022.100259 · Cited by 198
The Role of Fusobacterium nucleatum in Oral and Colorectal Carcinogenesis
Pignatelli, P., Nuccio, F., Piattelli, A., & Curia, M. C. (2023) · Microorganisms · doi:10.3390/microorganisms11092358 · Cited by 184
Molecular mechanisms of the preventable causes of cancer in the United States
Golemis, E. A., Scheet, P., Beck, T. N., Scolnick, E. M., Hunter, D. J., Hawk, E., & Hopkins, N. (2018) · Genes & Development · doi:10.1101/gad.314849.118 · Cited by 153
“In an exciting recent report, biofilms containing two specific species of bacteria were implicated in specifically elevating inflammation and increasing tumor formation in mouse models and in patients with hereditary risk factors for colon cancer (Dejea et al. 2018).”
BackgroundCancer and stress: NextGen strategies
Cui, B., Peng, F., Lu, J., He, B., Su, Q., Luo, H., Deng, Z., Jiang, T., Su, K., Huang, Y., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.005 · Cited by 152
“Both Escherichia coli and Bacteroides fragilis promoted tumor initiation in a mouse model (Dejea et al., 2018).”
BackgroundBiofilm formation – what we can learn from recent developments
Bjarnsholt, T., Buhlin, K., Dufrêne, Y. F., Gomelsky, M., Moroni, A., Ramstedt, M., Rumbaugh, K. P., Schulte, T., Sun, L., Åkerlund, B., et al. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12782 · Cited by 161
Xu, Y., Zhang, Y., Li, J., An, J., Li, C., Bai, S., Sharma, A., Deng, G., Kim, J. S., & Sun, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120315 · Cited by 150
Fan, Z., Tang, P., Li, C., Yang, Q., Xu, Y., Su, C., & Li, L. (2023) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2145729 · Cited by 150
Metadata
- Authors
- Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., Anders, R. A., Giardiello, F. M., Wick, E. C., Wang, H., Wu, S., Pardoll, D. M., Housseau, F., & Sears, C. L.
- Affiliations
- Johns Hopkins University (US)
- Radboud University Medical Center (NL)
- Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA.
- Corresponding author
- Sears, Cynthia L.
- ORCID
- Venue
- Science
- Published
- 2018-02-02
- Volume
- 359
- Issue
- 6375
- Pages
- 592-597
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5881113
- OpenAlex
- W2786541232
- Cited by
- 1,105
- References
- 17
- Citations by year
- 2026: 119 · 2025: 134 · 2024: 155 · 2023: 128 · 2022: 140 · 2021: 147 · 2020: 117 · 2019: 106 · 2018: 55
- FWCI
- 37.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (R01CA151393, K08DK087856, 5T32CA126607, P30DK089502)
- National Cancer Institute (P30CA006973, P50CA62924)
- Alexander and Margaret Stewart Trust (300-2344)
- Bristol Myers Squibb International Immuno-Oncology Network
- Netherlands Organization of Scientific Research (NWO825.11.03, 016.166.089)
- Institute Merieux
- American Society of Colon and Rectal Surgeons (GSRRIG-015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- familial adenomatous polyposis, Escherichia coli, Bacteroides fragilis, colitis-associated colorectal cancer, colonic inflammation, polyps, tumor formation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacterial Toxins, Bacteroides fragilis, Colon, Colonic Neoplasms, DNA Damage, Escherichia coli, Humans, Intestinal Mucosa, Metalloendopeptidases, Peptides, Adenomatous Polyposis Coli, Precancerous Conditions, Biofilms, Interleukin-17, Mice, Polyketides, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.